Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#161 / 200 Total
AXTI - AXT Inc - Stock Price Chart
TickerAXTI [NASD]
CompanyAXT Inc
CountryUSA
IndustrySemiconductor Equipment & Materials
Market Cap153.62MEPS (ttm)-0.39
P/E-EPS this Y64.71%
Forward P/E23.86EPS next Y220.83%
PEG-EPS past 5Y-
P/S1.94EPS next 5Y15.00%
P/B0.78EPS Q/Q37.97%
Dividend-Sales Q/Q16.92%
Insider Own6.90%Inst Own57.60%
Insider Trans0.00%Inst Trans3.46%
Short Float2.42%EarningsMay 02/a
Analyst Recom1.00Target Price5.50
Avg Volume1.23M52W Range1.89 - 5.64
AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.
AVRO - AvroBio Inc - Stock Price Chart
TickerAVRO [NASD]
CompanyAvroBio Inc
CountryUSA
IndustryBiotechnology
Market Cap67.78MEPS (ttm)0.69
P/E2.19EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.76EPS Q/Q73.18%
Dividend-Sales Q/Q-
Insider Own13.41%Inst Own57.42%
Insider Trans14.59%Inst Trans-6.02%
Short Float0.47%Earnings-
Analyst Recom1.00Target Price2.00
Avg Volume220.60K52W Range0.88 - 1.65
Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. The firm's clinical-stage programs include Fabry, Gaucher Type 1, Hunter syndrome Gaucher Type 3, Pompe, and Cystinosis. The company was founded by Geoff Mackay, Kim Warren, Christopher Mason, and Jeffrey Medin in 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Leonard Braden Michael10% OwnerMay 14 '24Buy1.30296,882385,9474,768,262May 15 11:21 AM
Leonard Braden Michael10% OwnerMay 13 '24Buy1.25469,753585,5464,471,380May 15 11:21 AM
Golipour AzadehChief Technology OfficerFeb 01 '24Option Exercise0.0037,334068,104Feb 05 08:01 PM
Ostrowski ErikInterim CEO, President and CFOFeb 01 '24Option Exercise0.0040,084042,384Feb 05 07:57 PM
Ridha EssraChief Medical OfficerFeb 01 '24Option Exercise0.0032,834032,834Feb 05 07:59 PM
TKNO - Alpha Teknova Inc - Stock Price Chart
TickerTKNO [NASD]
CompanyAlpha Teknova Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap74.70MEPS (ttm)-1.05
P/E-EPS this Y41.16%
Forward P/E-EPS next Y13.19%
PEG-EPS past 5Y-113.92%
P/S2.03EPS next 5Y-
P/B0.90EPS Q/Q36.59%
Dividend-Sales Q/Q1.85%
Insider Own74.24%Inst Own14.69%
Insider Trans0.04%Inst Trans-1.24%
Short Float0.34%EarningsMay 13/a
Analyst Recom1.80Target Price5.50
Avg Volume11.19K52W Range1.66 - 4.27
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gelhaus KenChief Commercial OfficerNov 30 '23Buy1.733,5876,22022,924Dec 01 05:44 PM
Telegraph Hill Partners IV, L.10% OwnerSep 19 '23Buy1.856,917,83712,797,99821,859,660Sep 21 08:58 PM
Telegraph Hill Partners IV, L.10% OwnerSep 19 '23Buy1.851,190,2702,202,0003,761,132Sep 21 08:58 PM
MACKOWSKI J MATTHEWDirectorSep 19 '23Buy1.85810,8101,499,998810,810Sep 21 05:04 PM
Gunstream StephenPresident and CEOSep 19 '23Buy1.8554,054100,000162,852Sep 21 05:03 PM
SDIG - Stronghold Digital Mining Inc - Stock Price Chart
TickerSDIG [NASD]
CompanyStronghold Digital Mining Inc
CountryUSA
IndustryCapital Markets
Market Cap39.69MEPS (ttm)-3.00
P/E-EPS this Y88.87%
Forward P/E-EPS next Y6.02%
PEG-EPS past 5Y-68.53%
P/S0.47EPS next 5Y-
P/B0.64EPS Q/Q105.40%
Dividend-Sales Q/Q59.40%
Insider Own16.06%Inst Own16.94%
Insider Trans-15.26%Inst Trans2.73%
Short Float3.49%EarningsMay 02/b
Analyst Recom1.67Target Price7.17
Avg Volume484.65K52W Range1.65 - 11.56
Stronghold Digital Mining, Inc. is a vertically integrated crypto asset mining company, which engages in mining Bitcoin. It operates the Energy Operations and Cryptocurrency Operations segments. The company was founded by Gregory Allan Beard and William B. Spence on March 19, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Matthew J.Chief Financial OfficerMay 03 '24Sale3.29132434174,207May 07 06:01 PM
Shaffer Richard J.Senior Vice PresidentMay 01 '24Sale3.124313427,125May 02 05:41 PM
Smith Matthew J.Chief Financial OfficerApr 23 '24Sale3.65107391174,339Apr 24 07:15 PM
Beard Gregory AChief Executive OfficerApr 15 '24Sale2.3813,81132,818374,003Apr 17 07:33 PM
Smith Matthew J.Chief Financial OfficerMar 20 '24Sale4.04166670174,446Mar 22 06:32 PM
TELO - Telomir Pharmaceuticals Inc - Stock Price Chart
TickerTELO [NASD]
CompanyTelomir Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap199.57MEPS (ttm)-0.65
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B66.16EPS Q/Q-1281.60%
Dividend-Sales Q/Q-
Insider Own42.48%Inst Own0.27%
Insider Trans1.11%Inst Trans-
Short Float0.23%Earnings-
Analyst Recom-Target Price-
Avg Volume45.72K52W Range4.76 - 20.72
May-24-24 09:30AM New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET (GlobeNewswire) +6.98%
May-16-24 09:30AM Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support (GlobeNewswire)
May-13-24 10:53PM TELO Stock Earnings: Telomir Pharmaceuticals Reported Results for Q1 2024 (InvestorPlace)
May-07-24 03:02PM Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1 (News Direct)
Apr-16-24 08:30AM Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C. (GlobeNewswire) -5.32%
Apr-02-24 08:30AM Telomir Pharmaceuticals' Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024 (GlobeNewswire)
Mar-29-24 04:44PM UPDATE Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines (GlobeNewswire)
Mar-26-24 08:30AM Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines (GlobeNewswire)
Mar-22-24 08:30AM Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th (GlobeNewswire)
Mar-14-24 08:30AM Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate's Potential in DNA Age Reversal Science (GlobeNewswire) -9.83%
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company, which focuses on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells. The firm's initial focus on treatments to inhibit the production of pro-inflammatory cytokines, such as IL-17, by oral administration of TELOMIR-1 as a therapeutic treatment for stem cells in situ. TELOMIR-1 is under investigation to provide a potential therapeutic intervention against age-related inflammatory conditions such as hemochromatosis, as well as for post-chemotherapy recovery, by interrupting and preventing the IL-17 induced inflammatory pathways that create the systemic imbalance of cellular metals. The company was founded by Christopher C. Chapman Jr. on August 26, 2021 and is headquartered in Baltimore, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bay Shore Trust10% OwnerFeb 13 '24Buy7.00138,000966,0005,455,431Feb 15 04:11 PM
MOND - Mondee Holdings Inc - Stock Price Chart
TickerMOND [NASD, RUT]
CompanyMondee Holdings Inc
CountryUSA
IndustryTravel Services
Market Cap203.96MEPS (ttm)-1.02
P/E-EPS this Y-19.51%
Forward P/E-EPS next Y61.22%
PEG-EPS past 5Y-
P/S0.88EPS next 5Y-
P/B-EPS Q/Q-92.28%
Dividend-Sales Q/Q16.21%
Insider Own59.42%Inst Own10.92%
Insider Trans0.00%Inst Trans-49.83%
Short Float9.73%EarningsMay 10/b
Analyst Recom1.00Target Price3.96
Avg Volume112.62K52W Range1.92 - 13.20
Mondee Holdings Inc. is a travel technology company, which engages in the provision of a state-of-the art platform, technologies, apps, operating systems, and technology-enabled services that seamlessly facilitate travel transactions to serve travelers through travel affiliates and emerging channels. It operates through the Travel Marketplace and SAAS Platform segments. The Travel Marketplace segment is involved in the selling of airline tickets through a proprietary platform. The SAAS Platform segment offers corporate travel cost savings solutions through its own technology platform. The company was founded by Prasad Gundumogula in 2011 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gundumogula PrasadChief Executive OfficerAug 23 '23Buy6.3620,000127,2009,901,494Aug 24 06:05 AM
Gundumogula PrasadChief Executive OfficerAug 22 '23Buy6.5310,00065,3009,881,494Aug 23 06:03 AM
Gundumogula PrasadChief Executive OfficerAug 21 '23Buy6.745,00033,7009,871,494Aug 22 06:04 AM
Gundumogula PrasadChief Executive OfficerAug 18 '23Buy6.6411,00073,0409,866,494Aug 21 06:19 AM
Gundumogula PrasadChief Executive OfficerAug 17 '23Buy6.0437,000223,4809,855,494Aug 18 06:38 AM
LAES - SEALSQ Corp - Stock Price Chart
TickerLAES [NASD]
CompanySEALSQ Corp
CountrySwitzerland
IndustrySemiconductors
Market Cap30.41MEPS (ttm)-0.23
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.95EPS next 5Y-
P/B4.11EPS Q/Q-142.67%
Dividend-Sales Q/Q33.08%
Insider Own47.48%Inst Own3.10%
Insider Trans0.00%Inst Trans-
Short Float2.35%Earnings-
Analyst Recom1.00Target Price3.00
Avg Volume745.84K52W Range0.91 - 26.42
SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.
NTRB - Nutriband Inc - Stock Price Chart
TickerNTRB [NASD]
CompanyNutriband Inc
CountryUSA
IndustryBiotechnology
Market Cap55.95MEPS (ttm)-0.69
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.27%
P/S26.77EPS next 5Y-
P/B7.02EPS Q/Q-7.04%
Dividend-Sales Q/Q-0.55%
Insider Own52.35%Inst Own2.31%
Insider Trans0.00%Inst Trans12.60%
Short Float0.54%Earnings-
Analyst Recom1.00Target Price18.00
Avg Volume53.54K52W Range1.53 - 6.00
Nutriband, Inc. engages in the development of a portfolio of transdermal pharmaceutical products. It operates through the Pocono Pharmaceuticals and 4P Therapeutics segments. The Pocono Pharmaceuticals segment relates to a coated products manufacturing entity. The 4P Therapeutics segment performs contract research and development services. The company was founded by Gareth R. Sheridan and Serguei Melnik in 2012 and is headquartered in Orlando, FL.
HYMC - Hycroft Mining Holding Corporation - Stock Price Chart
TickerHYMC [NASD]
CompanyHycroft Mining Holding Corporation
CountryUSA
IndustryGold
Market Cap82.47MEPS (ttm)-3.02
P/E-EPS this Y6.51%
Forward P/E-EPS next Y81.97%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-1336.60%
Dividend-Sales Q/Q-
Insider Own21.37%Inst Own6.82%
Insider Trans0.00%Inst Trans-6.61%
Short Float8.57%EarningsMay 08/b
Analyst Recom2.00Target Price130.00
Avg Volume534.79K52W Range1.63 - 4.99
Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GARRETT DIANE RPresident & CEOJun 05 '23Sale0.3467,62923,1292,125,447Jun 07 06:46 PM
RIDEOUT STANTON KExecutive Vice President & CFOJun 05 '23Sale0.3445,62115,6021,099,177Jun 07 06:44 PM
RIDEOUT STANTON KExecutive Vice President & CFOMay 31 '23Sale0.342,1007161,144,798Jun 01 08:10 PM
PROP - Prairie Operating Co - Stock Price Chart
TickerPROP [NASD]
CompanyPrairie Operating Co
CountryUSA
IndustryCapital Markets
Market Cap155.18MEPS (ttm)-13.92
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.32%
P/S100.12EPS next 5Y-
P/B3.66EPS Q/Q63.71%
Dividend-Sales Q/Q-
Insider Own53.46%Inst Own13.15%
Insider Trans0.00%Inst Trans-
Short Float0.96%Earnings-
Analyst Recom1.00Target Price15.50
Avg Volume108.32K52W Range2.29 - 18.50
Prairie Operating Co. engages in development, exploration, and production of oil, natural gas, and natural gas liquids. It focuses on unconventional oil and natural gas reservoirs located in Colorado focused on the Niobrara and Codell formations. The company is also a crypto company involved in cryptocurrency mining. Prairie Operating was founded by Gary C. Hanna and Edward Kovalik on May 2, 2001 and is headquartered in Houston, TX.
110121314151617181920